University of Thessaly (UTH)
Χρήση κολπικών διαστολέων και αξιολόγηση της σεξουαλικής λειτουργίας μετά από ακτινοθεραπεία πυέλου σε ασθενείς με γυναικολογικό καρκίνο: μία προοπτική μελέτη
Abstract
dc:descriptionIntroduction. Over the past few decades, pelvic radiotherapy (RT) is an essential tool in the treatment of endometrial and cervical cancer. More advanced RT techniques can allow dose escalation and improve long-term tumor control rates. However, external beam radiotherapy (EBRT) and brachytherapy (BT) can lead to vaginal stenosis (VS) and sexual dysfunction substantially impairing sexual quality of life (QoL) of patients. Since continuing advances in radiotherapy (RT) technology broaden the role of RT in the treatment of gynecologic malignancies, the use of vaginal dilators (VD) has been introduced in order to mitigate the risk of radiation-induced toxicities like vaginal stenosis (VS) and sexual dysfunction. Objectives. The main aim of this study is to evaluate the effect of VD usage on VS and sexual QoL after RT in endometrial and cervical cancer survivors. Furthermore, we assess the association of radiotherapy with sexual dysfunction. Material-Methods. We studied fifty-three patients with endometrial or cervical cancer treated with radical or adjuvant external beam radiotherapy and/or brachytherapy, from November of 2017 to October of 2019. All patients were oriented to use VD for 12 consecutive months after the end of therapy.They were routinely examined at the end of RT, 3 months, 6 months, and 12 months after the onset of VD use. At the same time, they were asked to fill out a validated sexual function-vaginal changes questionnaire. An SPSS version 20 and Minitab version 16 were used for statistical analysis of the results. A p-value less than 0.05 was considered as statistically significant. Results. The VS grading score was decreased, the size of VD comfortably insertable was gradually increased while radiation-induced vaginal and sexual symptoms were improved throughout the year of VD use. More specifically, all patients with initial grade 3 VS showed a grade 2 after 12 months of VD use and 65.8% of the patients with grade 2 initial VS demonstrated final VS grade 1 while 77.8% of the participants with initial 1st size of VD reached the 3rd size after 12 months (p-value<0.001). Starting time of VD therapy <= 3 months after the end of RT was associated with significant decrease in VS (p-value<0.001). A percentage of 60.9% answered that they did not feel at all their vagina too small during intercourse after 12 months of dilation whereas there was only 11.5% with the same answer before the start of dilation. Furthermore, 47.17% gave a score of 5 out of 7 when they were asked to rate their satisfaction with their sexual and only 3.77% gave a score of 3 at 12-month dilation (p-value=0.000). Strengths & Limitations. The adherence to VD therapy was high. Extensive psychological and practical support was given throughout the 12 months of dilation while all participants were provided with written instructions on VD use and Kegel exercises to relax pelvic muscles. The measuring devices were mainly subjenctive and there was no pre-RT measurement of vaginal dimensions. The absence of control group, the sample size and the 12-month follow up time compromise the power of this study. Conclusion. Endometrial and cervical cancer survivors are encouraged to use VD for the treatment of VS and sexual rehabilitation after RT. Furthermore, this study recommends vaginal dilation with starting time no more than 3 months after treatment at least 2-3 times a week for 10-15 minutes and for 12 months. However, larger well-designed randomized clinical trials should be performed leading to specific international guidelines concerning the use and efficacy of vaginal dilators in vaginal stenosis and sexual QoL after radiotherapy for gynecological cancer.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2022
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Charatsi, Dimitra
- Χαρατσή, Δήμητρα
Subjects
dc:subject × 18- Κολπική στένωση
- Κολπικοί διαστολείς
- Καρκίνος ενδομητρίου
- Καρκίνος τραχήλου
- Ακτινοθεραπεία πυέλου
- Σεξουαλική δυσλειτουργία
- Vaginal stenosis
- Vaginal dilators
- Endometrial cancer
- Cervical cancer
- Pelvic radiotherapy
- Sexual dysfunction
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Μαιευτική και Γυναικολογία
- Clinical Medicine
- Medical and Health Sciences
- Obstetrics and Gynecology
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/51284